Mariner, LLC Atri Cure, Inc. Transaction History

Mariner, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$41.12 - $57.73 $3,659 - $5,137	89 Added 1.82%	4,966 $217,000
Q2 2023 Aug 11, 2023	SELL	$40.44 - $49.6 $9,665 - $11,854	-239 Reduced 4.67%	4,877 $240,000
Q1 2023 May 12, 2023	SELL	$35.87 - $47.22 $21,486 - $28,284	-599 Reduced 10.48%	5,116 $212,000
Q4 2022 Feb 14, 2023	BUY	$33.48 - $47.45 $11,282 - $15,990	337 Added 6.27%	5,715 $254,000
Q3 2022 Nov 10, 2022	BUY	$38.25 - $52.62 $205,708 - $282,990	5,378 New	5,378 $210,000

213

49.6M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.83B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.